Molecular mechanism of Xuebijing in treating pyogenic liver abscess complicated with sepsis

doi:10.5847/wjem.j.1920-8642.2024.016

Abstract

Abstract:

BACKGROUND: Xuebijing (XBJ) can alleviate the inflammatory response, improve organ function, and shorten the intensive care unit (ICU) stay in patients with pyogenic liver abscess (PLA) complicated with sepsis, but the molecular mechanisms have not been elucidated. This study aimed to explore the molecular mechanism of XBJ in treating PLA complicated with sepsis using a network pharmacology approach.
METHODS: The active ingredients and targets of XBJ were retrieved from the ETCM database. Potential targets related to PLA and sepsis were retrieved from the GeneCards, PharmGKB, DisGeNet, Online Mendelian Inheritance in Man (OMIM), Therapeutic Targets Database (TTD), and DrugBank databases. The targets of PLA complicated with sepsis were mapped to the targets of XBJ to identify potential treatment targets. Protein-protein interaction networks were analyzed using the STRING database. Potential treatment targets were imported into the Metascape platform for Gene Ontology (GO) functional enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses. Molecular docking was performed to validate the interactions between active ingredients and core targets.
RESULTS: XBJ was found to have 54 potential treatment targets for PLA complicated with sepsis. Interleukin-1β (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor (TNF) were identified as core targets. KEGG enrichment analysis revealed important pathways, including the interleukin-17 (IL-17) signaling pathway, the TNF signaling pathway, the nuclear factor-kappa B (NF-κB) signaling pathway, and the Toll-like receptor (TLR) signaling pathway. Molecular docking experiments indicated stable binding between XBJ active ingredients and core targets.
CONCLUSION: XBJ may exert therapeutic effects on PLA complicated with sepsis by modulating signaling pathways, such as the IL-17, TNF, NF-κB, and TLR pathways, and targeting IL-1β, IL-6, and TNF.

Key words: Xuebijing injection, Pyogenic liver abscess, Sepsis

Wei Zhou, Maiying Fan, Xiang Li, Fang Yu, En Zhou, Xiaotong Han. Molecular mechanism of Xuebijing in treating pyogenic liver abscess complicated with sepsis[J]. World Journal of Emergency Medicine, 2024, 15(1): 35-40.

Figures/Tables 4

Figure 1.

Figure 2.

Table 1.

Figure 3.

References 25

1	Li WF, Chen HJ, Wu S, Peng J. A comparison of pyogenic liver abscess in patients with or without diabetes: a retrospective study of 246 cases. BMC Gastroenterol. 2018; 18(1):144. doi: 10.1186/s12876-018-0875-y pmid: 30285638
2	Qi WQ, Huang CM, Bian F, Ge Q. Risk factors and early diagnosis of sepsis caused by liver abscess. Chin J Emerg Med. 2019; 28:1383-9.
3	Wei JX, Jiang HL, Chen XH. Endothelial cell metabolism in sepsis. World J Emerg Med. 2023; 14(1):10-6. doi: 10.5847/wjem.j.1920-8642.2023.019
4	Liu S, Yao C, Xie J, Liu H, Wang H, Lin Z, et al. Effect of an herbal-based injection on 28-day mortality in patients with sepsis: the EXIT-SEP randomized clinical trial. JAMA Intern Med. 2023; 183(7):647-55. doi: 10.1001/jamainternmed.2023.0780 pmid: 37126332
5	Meng X, Yang S, Cao Y, Zhao M. The clinical effect of Xuebijing on the patients with bacterial liver abscess and sepsis. Chin J Critical Care Med. 2019, 39(11):1050-2.
6	Li X, Wei SZ, Niu SQ, Ma X, Li HT, Jing MY, et al. Network pharmacology prediction and molecular docking-based strategy to explore the potential mechanism of Huanglian Jiedu Decoction against sepsis. Comput Biol Med. 2022; 144: 105389. doi: 10.1016/j.compbiomed.2022.105389
7	Liu JQ, Liu J, Tong XL, Peng WJ, Wei SS, Sun TL, et al. Network pharmacology prediction and molecular docking-based strategy to discover the potential pharmacological mechanism of Huai Hua San against ulcerative colitis. Drug Des Dev Ther. 2021; 15: 3255-76. doi: 10.2147/DDDT.S319786 pmid: 34349502
8	Zhou YY, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019; 10(1):1523. doi: 10.1038/s41467-019-09234-6 pmid: 30944313
9	Zhou W, Fan M, Tang Y, Guo H, Tan Z, Han X, et al. Effect of Xuebijing on inflammatory response and clinical efficacy in patients with sepsis. Int J Urol Nephrol. 2023; 43(1):97-100.
10	Zhao L, Chen F, Zhang YL, Yue L, Guo HR, Ye G, et al. Involvement of P450s and nuclear receptors in the hepatoprotective effect of quercetin on liver injury by bacterial lipopolysaccharide. Immunopharmacol Immunotoxicol. 2020; 42(3):211-20. doi: 10.1080/08923973.2020.1742154
11	Tang J, Diao P, Shu XH, Li L, Xiong LD. Quercetin and quercitrin attenuates the inflammatory response and oxidative stress in LPS-induced RAW264.7 cells: in vitro assessment and a theoretical model. Biomed Res Int. 2019; 2019:7039802.
12	Karimi A, Naeini F, Asghari Azar V, Hasanzadeh M, Ostadrahimi A, Niazkar HR, et al. A comprehensive systematic review of the therapeutic effects and mechanisms of action of quercetin in sepsis. Phytomedicine. 2021; 86:153567. doi: 10.1016/j.phymed.2021.153567
13	Zhang ZH, Yang HX, Jin Q, Wu YL, Cui ZY, Shang Y, et al.Luteolin attenuates hepatic injury in septic mice by regulating P2X7R-based HMGB1 release. Food Funct. 2021; 12(21): 10714-27. doi: 10.1039/D1FO01746B
14	Vajdi M, Karimi A, Karimi M, Abbasalizad Farhangi M, Askari G. Effects of luteolin on sepsis: a comprehensive systematic review. Phytomedicine. 2023; 113:154734. doi: 10.1016/j.phymed.2023.154734
15	Gao J, Yin J, Shen WJ, Shen W, Wang SY, Yao P. The effect of kaempferol on liver function injury in septic rats and its relationship with HIF-1α/HK2 signaling pathway. Chin J Crit Care Med. 2023; 43(4):279-84.
16	Zhu X, Wang XL, Ying TH, Li XL, Tang YD, Wang YF, et al. Kaempferol alleviates the inflammatory response and stabilizes the pulmonary vascular endothelial barrier in LPS-induced sepsis through regulating the SphK1/S1P signaling pathway. Chem Biol Interact. 2022; 368:110221. doi: 10.1016/j.cbi.2022.110221
17	Guo HL, Shi FD, Zhou Q, Liu QY, Wang YX, Song Y, et al. Interleukin-1β protection against experimental sepsis in mice. Inflammation. 2021; 44(1):358-70. doi: 10.1007/s10753-020-01341-7
18	Xiong SQ, Hong ZG, Huang LS, Tsukasaki Y, Nepal S, Di AK, et al. IL-1β suppression of VE-cadherin transcription underlies sepsis-induced inflammatory lung injury. J Clin Invest. 2020; 130(7):3684-98. doi: 10.1172/JCI136908 pmid: 32298238
19	Cao J, Liu WG, Li Y, Chen B, Yu TF, He ZB, et al. Value of IL-1β and IL-23 in predicting 28-day mortality due to sepsis: a retrospective study. Med Sci Monit. 2023; 29:e940163.
20	Roderburg C, Benz F, Schüller F, Pombeiro I, Hippe HJ, Frey N, et al. Serum levels of TNF receptor ligands are dysregulated in sepsis and predict mortality in critically ill patients. PLoS One. 2016; 11(4):e0153765. doi: 10.1371/journal.pone.0153765
21	Tiegs G, Horst AK. TNF in the liver: targeting a central player in inflammation. Semin Immunopathol. 2022; 44(4):445-59. doi: 10.1007/s00281-022-00910-2 pmid: 35122118
22	Guo Y, Chen L, Zheng Q, Chen J, Cai J, Cao H, et al. Effects of inhibition of IL-6/STAT3 signaling pathway on liver injury in septic rats. Chin J Trauma. 2011; 27(11):1049-52.
23	Hu P, Chen Y, Pang J, Chen X. Association between IL-6 polymorphisms and sepsis. Innate Immun. 2019; 25(8):465-72. doi: 10.1177/1753425919872818
24	Kumar V.Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets. Int Immunopharmacol. 2020; 89(Pt B):107087. doi: 10.1016/j.intimp.2020.107087
25	Yan BL, Chen F, Xu LJ, Xing JH, Wang XF. HMGB1-TLR4-IL23-IL17A axis promotes paraquat-induced acute lung injury by mediating neutrophil infiltration in mice. Sci Rep. 2017; 7:597. doi: 10.1038/s41598-017-00721-8 pmid: 28377603

[1]	Quan Li, Yun Qu, Jinfang Xue, Hai Kang, Chuanzhu Lyu. Exploring lipid-modifying therapies for sepsis through the modulation of circulating inflammatory cytokines: a Mendelian randomization study [J]. World Journal of Emergency Medicine, 2025, 16(3): 256-261.
[2]	Peili Chen, Yan Ge, Huiqiu Sheng, Wenwu Sun, Jiahui Wang, Li Ma, Enqiang Mao. The role of early changes in routine coagulation tests in predicting the occurrence and prognosis of sepsis [J]. World Journal of Emergency Medicine, 2025, 16(2): 136-143.
[3]	Chunxue Wang, Dianyin Yang, Yuxin Zhu, Qian Yang, Tong Liu, Xiandong Liu, Dongyang Zhao, Xiaowei Bao, Tiancao Dong, Li Shao, Lunxian Tang. Circulating circular RNAs act as potential novel biomarkers for sepsis secondary to pneumonia: a prospective cohort study [J]. World Journal of Emergency Medicine, 2025, 16(2): 144-152.
[4]	Azzah S Alharbi, Raghad Hassan Sanyi, Esam I Azhar. Bacteria and host: what does this mean for sepsis bottleneck? [J]. World Journal of Emergency Medicine, 2025, 16(1): 10-17.
[5]	Chao Gong, Shengyong Xu, Youlong Pan, Shigong Guo, Joseph Harold Walline, Xue Wang, Xin Lu, Shiyuan Yu, Mubing Qin, Huadong Zhu, Yanxia Gao, Yi Li. Effects of probiotic treatment on the prognosis of patients with sepsis: a systematic review [J]. World Journal of Emergency Medicine, 2025, 16(1): 18-27.
[6]	Jingyuan Xie, Jiandong Gao, Mutian Yang, Ting Zhang, Yecheng Liu, Yutong Chen, Zetong Liu, Qimin Mei, Zhimao Li, Huadong Zhu, Ji Wu. Prediction of sepsis within 24 hours at the triage stage in emergency departments using machine learning [J]. World Journal of Emergency Medicine, 2024, 15(5): 379-385.
[7]	Juexian Wei, Hengzong Mo, Yuting Zhang, Wenmin Deng, Siqing Zheng, Haifeng Mao, Yang Ji, Huilin Jiang, Yongcheng Zhu. Evolutionary trend analysis and knowledge structure mapping of endothelial dysfunction in sepsis: a bibliometrics study [J]. World Journal of Emergency Medicine, 2024, 15(5): 386-396.
[8]	Rex Pui Kin Lam, Zonglin Dai, Eric Ho Yin Lau, Carrie Yuen Ting Ip, Ho Ching Chan, Lingyun Zhao, Tat Chi Tsang, Matthew Sik Hon Tsui, Timothy Hudson Rainer. Comparing 11 early warning scores and three shock indices in early sepsis prediction in the emergency department [J]. World Journal of Emergency Medicine, 2024, 15(4): 273-282.
[9]	Huixin Zhao, Yiming Dong, Sijia Wang, Jiayuan Shen, Zhenju Song, Mingming Xue, Mian Shao. Comparison between sepsis-induced coagulopathy and sepsis-associated coagulopathy criteria in identifying sepsis-associated disseminated intravascular coagulation [J]. World Journal of Emergency Medicine, 2024, 15(3): 190-196.
[10]	A-ling Tang, Yan Li, Li-chao Sun, Xiao-yu Liu, Nan Gao, Sheng-tao Yan, Guo-qiang Zhang. Xuebijing improves intestinal microcirculation dysfunction in septic rats by regulating the VEGF-A/PI3K/Akt signaling pathway [J]. World Journal of Emergency Medicine, 2024, 15(3): 206-213.
[11]	Qing Zhao, Jinfu Ma, Jianguo Xiao, Zhe Feng, Hui Liu. Data driven analysis reveals prognostic genes and immunological targets in human sepsis-associated acute kidney injury [J]. World Journal of Emergency Medicine, 2024, 15(2): 91-97.
[12]	Weichao Ding, Wei Zhang, Juan Chen, Mengmeng Wang, Yi Ren, Jing Feng, Xiaoqin Han, Xiaohang Ji, Shinan Nie, Zhaorui Sun. Protective mechanism of quercetin in alleviating sepsis-related acute respiratory distress syndrome based on network pharmacology and in vitro experiments [J]. World Journal of Emergency Medicine, 2024, 15(2): 111-120.
[13]	Jingyi Wang, Li Weng, Jun Xu, Bin Du. Blood gas analysis as a surrogate for microhemodynamic monitoring in sepsis [J]. World Journal of Emergency Medicine, 2023, 14(6): 421-427.
[14]	Saifeng Chen, Xuewei Hao, Guo Chen, Guorong Liu, Xiaoyan Yuan, Peiling Shen, Dongfeng Guo. Effects of mesencephalic astrocyte-derived neurotrophic factor on sepsis-associated acute kidney injury [J]. World Journal of Emergency Medicine, 2023, 14(5): 386-392.
[15]	Mubing Qin, Yanxia Gao, Shigong Guo, Xin Lu, Qian Zhao, Zengzheng Ge, Huadong Zhu, Yi Li. Establishment and evaluation of animal models of sepsis-associated encephalopathy [J]. World Journal of Emergency Medicine, 2023, 14(5): 349-353.